Baek B K, Kim B S, Choi I H, Yang K C, Hansen R, Kakoma I
College of Veterinary Medicine, Chonbuk National University, Chonju, Korea.
Kisaengchunghak Chapchi. 1992 Sep;30(3):201-8. doi: 10.3347/kjp.1992.30.3.201.
A Theileria sergenti soluble merozoite preparation containing the 29, 34, 35 and 105 KD as the immunodominant polypeptides, was evaluated for efficacy, safety and protectivity in Holstein calves against virulent field tick challenge. The soluble antigens (100 mg/dose) were fortified with either complete or incomplete Freund's adjuvant. Twenty naive calves, aged one month, were subcutaneously inoculated with the preparation and a booster dose was administered 4 weeks later. Twenty additional calves served as controls. Five weeks after the booster dose, vaccinates and uninoculated controls were moved to a pasture, a heavily tick infested area in Cheju-do, Korea. The vaccinates showed negligible change in hematocrit and total RBC count whereas control animals showed significant (p < 0.05) hematological changes and associated anemia. Only 30% of vaccinates required chemotherapy after the experiment was terminated. All control animals required chemotherapy and 25% received blood transfusion. The highest percent parasitized erythrocytes in vaccinated cattle was 0.4% as compared with 3.6% among controls during the month of July. A significant difference (p < 0.05) was observed in the rate of body weight increase. Significant differences were also noted in serum albumin, aspartate aminotransferase, total protein and bilirubin. Significantly more vaccinated cattle maintained normal ranges of hematological and biochemical values as compared with the control group. It is suggested that soluble merozoite T. sergenti antigens may be potential vaccine candidates for developing a genetic vaccine in Korea.
一种含有29、34、35和105千道尔顿免疫显性多肽的瑟氏泰勒虫可溶性裂殖子制剂,在荷斯坦犊牛中进行了针对强毒野外蜱虫攻击的效力、安全性和保护性评估。可溶性抗原(100毫克/剂量)用完全或不完全弗氏佐剂强化。20头1月龄的未感染犊牛皮下接种该制剂,并在4周后给予加强剂量。另外20头犊牛作为对照。加强剂量接种5周后,接种疫苗的犊牛和未接种的对照被转移到韩国济州岛一个蜱虫大量滋生的牧场。接种疫苗的犊牛血细胞比容和红细胞总数变化可忽略不计,而对照动物则出现了显著(p<0.05)的血液学变化及相关贫血。实验结束后,只有30%的接种疫苗犊牛需要化疗。所有对照动物都需要化疗,25%的对照动物接受了输血。7月份,接种疫苗的牛中寄生虫感染红细胞的最高百分比为0.4%,而对照组为3.6%。体重增加率也观察到显著差异(p<0.05)。血清白蛋白、天冬氨酸转氨酶、总蛋白和胆红素也有显著差异。与对照组相比,接种疫苗的牛中有更多保持了血液学和生化值的正常范围。提示瑟氏泰勒虫可溶性裂殖子抗原可能是韩国开发基因疫苗的潜在候选疫苗。